SG11201606546VA - Antibodies to matrix metalloproteinase 9 and methods of use thereof - Google Patents

Antibodies to matrix metalloproteinase 9 and methods of use thereof

Info

Publication number
SG11201606546VA
SG11201606546VA SG11201606546VA SG11201606546VA SG11201606546VA SG 11201606546V A SG11201606546V A SG 11201606546VA SG 11201606546V A SG11201606546V A SG 11201606546VA SG 11201606546V A SG11201606546V A SG 11201606546VA SG 11201606546V A SG11201606546V A SG 11201606546VA
Authority
SG
Singapore
Prior art keywords
antibodies
methods
matrix metalloproteinase
metalloproteinase
matrix
Prior art date
Application number
SG11201606546VA
Other languages
English (en)
Inventor
David L Gossage
Joseph Haw-Ling Lin
Victoria Smith
Maria Vaysberg
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of SG11201606546VA publication Critical patent/SG11201606546VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567Framework region [FR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201606546VA 2014-02-27 2015-02-25 Antibodies to matrix metalloproteinase 9 and methods of use thereof SG11201606546VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461945737P 2014-02-27 2014-02-27
PCT/US2015/017562 WO2015130813A1 (en) 2014-02-27 2015-02-25 Antibodies to matrix metalloproteinase 9 and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201606546VA true SG11201606546VA (en) 2016-09-29

Family

ID=52672334

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606546VA SG11201606546VA (en) 2014-02-27 2015-02-25 Antibodies to matrix metalloproteinase 9 and methods of use thereof

Country Status (13)

Country Link
US (1) US20150239988A1 (de)
EP (1) EP3110847A1 (de)
JP (1) JP2017507949A (de)
KR (1) KR20160125466A (de)
CN (1) CN106062001A (de)
AR (1) AR099604A1 (de)
AU (1) AU2015223139A1 (de)
CA (1) CA2940869A1 (de)
EA (1) EA201691414A1 (de)
MX (1) MX2016011177A (de)
SG (1) SG11201606546VA (de)
TW (1) TW201544511A (de)
WO (1) WO2015130813A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018170488A1 (en) * 2017-03-17 2018-09-20 Gilead Sciences, Inc. Method of purifying an antibody
US11000538B2 (en) * 2018-10-31 2021-05-11 Amorepacific Corporation Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside
WO2023278491A1 (en) * 2021-06-28 2023-01-05 Releviate, Llc Mmp-9 antibodies and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
EP0617706B1 (de) 1991-11-25 2001-10-17 Enzon, Inc. Multivalente antigen-bindende proteine
AU2002235692A1 (en) * 2001-02-23 2002-09-04 Biophage Inc. Methods and compositions for preventing and treating neutrophil-mediated diseases
WO2009111450A2 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 binding proteins
CN107184974A (zh) * 2012-02-29 2017-09-22 吉利德生物制剂公司 抗基质金属蛋白酶9的抗体
BR112014021477A2 (pt) * 2012-02-29 2018-06-12 Gilead Sciences Inc anticorpos para metaloproteinase de matriz 9

Also Published As

Publication number Publication date
EP3110847A1 (de) 2017-01-04
AU2015223139A1 (en) 2016-08-25
CN106062001A (zh) 2016-10-26
KR20160125466A (ko) 2016-10-31
WO2015130813A1 (en) 2015-09-03
JP2017507949A (ja) 2017-03-23
AR099604A1 (es) 2016-08-03
EA201691414A1 (ru) 2017-03-31
MX2016011177A (es) 2016-12-16
CA2940869A1 (en) 2015-09-03
TW201544511A (zh) 2015-12-01
US20150239988A1 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
IL279606A (en) Anti-TREM2 antibodies and methods of using them
HK1243102A1 (zh) 抗cd79b抗體和使用方法
HRP20181359T1 (hr) Anti-jagged1 protutijela i postupci uporabe
IL251868A0 (en) Anti-tim3 antibodies and methods of use
IL251165A0 (en) Anti-il-1beta antibodies and methods of their use
IL248399A0 (en) New anti-43rnf antibodies and methods of use
ZA201701674B (en) Novel anti-mfi2 antibodies and methods of use
IL247754A0 (en) Antibodies against mcam and related methods of use
IL251286A0 (en) Anti-pdgf-b antibodies and methods of use
SG11201606546VA (en) Antibodies to matrix metalloproteinase 9 and methods of use thereof
GB201421430D0 (en) Antibodies to Adam17 and uses thereof